Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Gene Therapy|May 24, 2003
The pyruvate dehydrogenase complex as a target for gene therapyPeter W Stacpoole, Renius Owen, Terence R FlottePlos One|September 19, 2014
First report of a deletion encompassing an entire exon in the homogentisate 1,2-dioxygenase gene causing alkaptonuriaMohammad Zouheir Habbal, Tarek Bou-Assi, Jun Zhu, et al.Molecular Cytogenetics|November 29, 2016
Enrichment of small pathogenic deletions at chromosome 9p24.3 and 9q34.3 involving DOCK8, KANK1, EHMT1 genes identified by using high-resolution oligonucleotide-single nucleotide polymorphism array analysisJia-Chi Wang, Loretta W Mahon, Leslie P Ross, et al.Expert Opinion on Medical Diagnostics|March 19, 2013
Clinical array comparative genomic hybridization: a new paradigmPatricia Chan, Arturo Anguiano, Kerri Hensley, et al.BMC Medical Genetics|May 3, 2013
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivationLauren S Marshall, Julie Simon, Tim Wood, et al.Molecular Genetics & Genomic Medicine|February 2, 2019
Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratoryCarrie Guy, Farnoosh Haji-Sheikhi, Charles M Rowland, et al.Molecular Cytogenetics|July 10, 2012
Characterization of a complex rearrangement involving duplication and deletion of 9p in an infant with craniofacial dysmorphism and cardiac anomaliesDaniel L Di Bartolo, Mohamed El Naggar, Renius Owen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2002
Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectorsRenius Owen, Ronald J Mandel, Chandramohan V Ammini, et al.Blood Advances|January 4, 2018
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screeningMarlise R Luskin, Marie N Discenza, Sarah Rae Easter, et al.Human Gene Therapy|January 18, 2006
Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vectorThomas J Conlon, Glenn Walter, Renius Owen, et al.Pageof 3